NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 06/24/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,735.5 mln
Float33.53 mln
Earnings Date08/18/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.19
Caution advised
1-Year Forecast
66.00
Fairly priced
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
0.02
Debt-free
ROE
-16.41
Negative
Business Description
GRAIL Inc. is a U.S.-based healthcare company focused on detecting multiple types of cancer at early stages through blood-based testing. Its flagship product, Galleri, screens for cancer in people over 50 who show no symptoms, while a separate test helps doctors reach faster conclusions for patients already suspected of having cancer. Founded in 2015 and based in Menlo Park, California, GRAIL also supports clinical research and offers tools that help track how cancer responds to treatment over time.
